Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc.（PRAX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PRAX · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
16
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Praxis Precision Medicines, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
PRAX 季度内部人买卖趋势
PRAX 内幕交易卖出 · PRAX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · PRAX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PRAX 高管卖出股份 · PRAX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 14, 2026 | Mastrocola Lauren PAO | Award | 127 | $21K | Form 4 |
| May 14, 2026 | Nemiroff Alex General Counsel and Secretary | Award | 78 | $13K | Form 4 |
| May 14, 2026 | Kelly Timothy Edwin CFO | Award | 121 | $20K | Form 4 |
| May 14, 2026 | Sniecinski Megan COO | Award | 89 | $15K | Form 4 |
| May 14, 2026 | Souza Marcio CEO · Director | Award | 126 | $21K | Form 4 |
| Feb 6, 2026 | Arbuckle Stuart A Director | Award | 478 | — | Form 4 |
| Feb 6, 2026 | Arbuckle Stuart A Director | Award | 688 | — | Form 4 |
| Feb 6, 2026 | KINDLER JEFFREY B Director | Award | 478 | — | Form 4 |
| Feb 6, 2026 | KINDLER JEFFREY B Director | Award | 688 | — | Form 4 |
| Jan 12, 2026 | Mastrocola Lauren PAO | Other | 344 | $95K | Form 4 |
| Jan 12, 2026 | Sniecinski Megan COO | Other | 885 | $244K | Form 4 |
| Jan 12, 2026 | Nemiroff Alex General Counsel and Secretary | Other | 768 | $212K | Form 4 |
| Jan 12, 2026 | Kelly Timothy Edwin CFO | Other | 943 | $260K | Form 4 |
| Jan 8, 2026 | Mastrocola Lauren PAO | Award | 3,750 | — | Form 4 |
| Jan 10, 2026 | Mastrocola Lauren PAO | Other | 367 | $106K | Form 4 |
| Jan 8, 2026 | Sniecinski Megan COO | Award | 9,625 | — | Form 4 |
| Jan 10, 2026 | Sniecinski Megan COO | Other | 1,087 | $314K | Form 4 |
| Jan 8, 2026 | Nemiroff Alex General Counsel and Secretary | Award | 6,875 | — | Form 4 |
| Jan 10, 2026 | Nemiroff Alex General Counsel and Secretary | Other | 917 | $265K | Form 4 |
| Jan 8, 2026 | Kelly Timothy Edwin CFO | Award | 8,800 | — | Form 4 |
| Jan 10, 2026 | Kelly Timothy Edwin CFO | Other | 1,335 | $385K | Form 4 |
| Jan 8, 2026 | Souza Marcio CEO · Director | Award | 27,640 | — | Form 4 |
| Jan 10, 2026 | Souza Marcio CEO · Director | Other | 4,252 | $1.23M⚡ | Form 4 |
| Jan 7, 2026 | Mastrocola Lauren PAO | Other | 35 | $10K | Form 4 |
| Jan 7, 2026 | Nemiroff Alex General Counsel and Secretary | Other | 89 | $26K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PRAX 内幕交易
PRAX 内幕交易
Praxis Precision Medicines, Inc.（PRAX）内幕交易数据来源于公司内部人（包括Mastrocola Lauren (PAO), Nemiroff Alex (General Counsel and Secretary), Adage Capital Management, L.P. (10 percent owner)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PRAX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Praxis Precision Medicines, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PRAX 内幕交易 · 5个问题Praxis Precision Medicines, Inc.（PRAX）的内部人包括高管和董事，如Mastrocola Lauren (PAO), Nemiroff Alex (General Counsel and Secretary), Adage Capital Management, L.P. (10 percent owner)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026